Thema
71050168A2
29
Boron Compounds
29
Glycine
Journal Article
29
TE7660XO1C
29
ixazomib
29
Research Support, Non-U.S. Gov't
23
Clinical Trial, Phase I
17
Proteasome Inhibitors
16
Multicenter Study
10
Antineoplastic Agents
9
Randomized Controlled Trial
8
7S5I7G3JQL
7
Clinical Trial, Phase II
7
Dexamethasone
7
multiple myeloma
7
F0P408N6V4
5
Lenalidomide
5
4Z8R6ORS6L
4
Clinical Trial, Phase III
4
Ixazomib
4
Thalidomide
4
pharmacokinetics
4
proteasome inhibitor
4
Multiple myeloma
3
Protease Inhibitors
3
Review
3
8N3DW7272P
2
Carbon Radioisotopes
2
Cyclophosphamide
2
Drugs, Investigational
2
Proteasome inhibitor
2
newly diagnosed
2
20S proteasome
1
7V68J5677O
1
ADME
1
AMS
1
Accelerator mass spectrometry
1
Activating Transcription Factor 3
1
Angiogenesis Inhibitors
1
Biotransformation
1
Blood Proteins
1
Boronic acid
1
CYP3A
1
Capsules
1
Carbon-14
1
China
1
Clarithromycin
1
Cytochrome P-450 CYP3A
1
Cytochrome P-450 CYP3A Inducers
1
mehr ...